Artículos (20) Publicaciones en las que ha participado algún/a investigador/a

2009

  1. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne

    Journal of Immunological Methods, Vol. 348, Núm. 1-2, pp. 1-8

  2. Biodegradation of phenol in a draft-tube spouted bed bioreactor with biomass attached to hydrogel particles

    WIT Transactions on Ecology and the Environment, Vol. 125, pp. 147-156

  3. Butyric acid-based feed additives help protect broiler chickens from Salmonella enteritidis infection

    Poultry Science, Vol. 88, Núm. 5, pp. 943-948

  4. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis

    International Archives of Allergy and Immunology, Vol. 149, Núm. 2, pp. 111-118

  5. Construction and evaluation of an ORFeome-based Brucella whole-genome DNA microarray

    Microbial Pathogenesis, Vol. 47, Núm. 4, pp. 189-195

  6. Design and influence of γ-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 5, pp. 563-572

  7. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children

    Vaccine, Vol. 27, Núm. 15, pp. 2089-2093

  8. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis

    International Journal of Antimicrobial Agents, Vol. 34, Núm. 5, pp. 482-485

  9. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections

    Diagnostic Microbiology and Infectious Disease, Vol. 63, Núm. 2, pp. 208-212

  10. Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activation

    Journal of Biological Chemistry, Vol. 284, Núm. 29, pp. 19493-19500

  11. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination

    Vaccine, Vol. 27, Núm. 35, pp. 4784-4790

  12. New adjuvants: From empiricism to science

    Expert Review of Vaccines, Vol. 8, Núm. 10, pp. 1333-1337

  13. Non-O1 Vibrio cholerae inguinal skin and soft tissue infection with bullous skin lesions in a patient with a penis squamous cell carcinoma

    Annals of Clinical Microbiology and Antimicrobials, Vol. 8

  14. Novel findings on trypanosomatid chemotherapy using DNA topoisomerase inhibitors

    Mini-Reviews in Medicinal Chemistry, Vol. 9, Núm. 6, pp. 674-686

  15. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria

    Vaccine, Vol. 27, Núm. 17, pp. 2379-2386

  16. Rebrote de parotiditis en la era vacunal. Factores implicados en un brote en Navarra, 2006-2007

    Medicina Clinica, Vol. 133, Núm. 20, pp. 777-782

  17. Survey of Listeria monocytogenes in ready-to-eat products: Prevalence by brands and retail establishments for exposure assessment of listeriosis in Northern Spain

    Food Control, Vol. 20, Núm. 11, pp. 986-991

  18. The differential interaction of Brucella and Ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens

    PLoS ONE, Vol. 4, Núm. 6

  19. The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

    British Journal of Cancer, Vol. 100, Núm. 6, pp. 932-940

  20. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation

    Journal of Bacteriology, Vol. 191, Núm. 19, pp. 5953-5963